Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups

Clinical trials examining insulin-like growth factor-I receptor (IGF1R)-targeting strategies have emphasized that better predictive biomarkers are required to improve patient selection. Immunohistochemical tumor-specific protein expression of IGF1R, insulin receptor (InsR), and phosphorylated IGF1R/...

Descripción completa

Detalles Bibliográficos
Autores principales: Björner, Sofie, Rosendahl, Ann H., Simonsson, Maria, Markkula, Andrea, Jirström, Karin, Borgquist, Signe, Rose, Carsten, Ingvar, Christian, Jernström, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354717/
https://www.ncbi.nlm.nih.gov/pubmed/28030849
http://dx.doi.org/10.18632/oncotarget.14082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354717/
https://www.ncbi.nlm.nih.gov/pubmed/28030849
http://dx.doi.org/10.18632/oncotarget.14082

Ejemplares similares